Nantahala Capital Management, LLC

Fundamental diversified ★Signal CIK 1472322
League rank
#190
in Fundamental diversified · #796 overall
Long book
$1.60B
Q1 2026
Positions
129
Top-10 weight
31%
concentration
Last quarter
+18.2%
SPY +14.8%
Turnover
27%
of book per quarter

Strategy in plain words

auto-generated from filings

Nantahala Capital Management, LLC is a diversified fundamental manager, running a $1.60B US long book across 129 positions.

The portfolio is moderately concentrated (top 10 ≈ 31% of the book). The portfolio is actively managed, with meaningful quarterly turnover. Current anchor positions: BANCORP INC/THE, HILTON GRAND VACATIONS INC, SOLENO THERAPEUTICS INC, BIOVENTUS INC - A, PELOTON INTERACTIVE INC-A.

Over the last 9 quarters its long book ran on average 3pp per quarter ahead of the S&P 500, beating the index in 6 of 9 quarters. We rate its filings as signal-bearing: position changes reflect genuine views.

Implied long-book return vs S&P 500

methodology: positions priced quarterly, no shorts/options
Fund long book S&P 500
Q1 2024
-10.4%
Q2 2024
+13.4%
Q3 2024
+8.5%
Q4 2024
-14.2%
Q1 2025
+11.1%
Q2 2025
+33.9%
Q3 2025
+12.2%
Q4 2025
-5.2%
Q1 2026
+18.2%

Sector allocation

Healthcare
55%
Other
12%
Consumer discretionary
9%
Services media
8%
Financials
7%
Communications
2%
Technology
2%
Industrials
2%

Long book by quarter

$1.01B
Q1 2024
$1.98B
Q2 2024
$1.19B
Q3 2024
$1.43B
Q4 2024
$1.21B
Q1 2025
$1.41B
Q2 2025
$1.62B
Q3 2025
$1.67B
Q4 2025
$1.60B
Q1 2026

What does Nantahala Capital own?

Q1 2026 13F
CompanySectorSharesValue% of bookChange
TBBK BANCORP INC/THEFinancials1.4M$74.2M4.6%+28.8%
HGV HILTON GRAND VACATIONS INCServices media1.5M$59.2M3.7%-3.1%
SLNOEUR SOLENO THERAPEUTICS INC1.7M$58.4M3.7%+32.7%
BVS BIOVENTUS INC - AHealthcare6.1M$55.9M3.5%+1.2%
PTON PELOTON INTERACTIVE INC-AOther12.0M$51.5M3.2%+102.3%
ESTA ESTABLISHMENT LABS HOLDINGSHealthcare833.0K$47.3M3.0%-15.7%
SVRA SAVARA INCHealthcare7.3M$40.1M2.5%Held
XTNT XTANT MEDICAL HOLDINGS INCHealthcare68.4M$38.2M2.4%Held
GOGO GOGO INCCommunications8.9M$35.7M2.2%+30.8%
AMRX AMNEAL PHARMACEUTICALS INCHealthcare2.8M$35.4M2.2%+16.2%
AVR ANTERIS TECHNOLOGIES GLOBALHealthcare5.5M$30.7M1.9%+118.5%
ETON ETON PHARMACEUTICALS INCHealthcare1.2M$29.0M1.8%Held
EOLS EVOLUS INCHealthcare6.4M$26.2M1.6%+9.6%
TNGX TANGO THERAPEUTICS INCHealthcare1.3M$26.2M1.6%-65.0%
LBRX LB PHARMACEUTICALS INCHealthcare1.1M$26.0M1.6%+56.0%
FOXF FOX FACTORY HOLDING CORPIndustrials1.5M$24.5M1.5%-32.0%
MLYS MINERALYS THERAPEUTICS INCHealthcare895.5K$24.3M1.5%+690.5%
ZVRA ZEVRA THERAPEUTICS INCHealthcare2.5M$23.5M1.5%+42.3%
FULC FULCRUM THERAPEUTICS INCHealthcare3.1M$23.4M1.5%-29.0%
FOSL FOSSIL GROUP INCOther5.4M$23.3M1.5%+6.7%
RDNW RIDENOW GROUP INCTechnology3.3M$23.1M1.4%Held
ABEO ABEONA THERAPEUTICS INCHealthcare5.0M$22.5M1.4%+1.0%
CWH CAMPING WORLD HOLDINGS INC-AConsumer discretionary3.3M$22.3M1.4%+207.9%
ADCT ADC THERAPEUTICS SAHealthcare5.6M$21.0M1.3%+2.2%
TITN TITAN MACHINERY INCConsumer discretionary1.3M$21.0M1.3%+2.8%
HLF HERBALIFE LTDConsumer discretionary1.4M$19.9M1.2%+53.5%
IMAX IMAX CORPOther515.6K$19.6M1.2%+8.1%
VSTM VERASTEM INCHealthcare3.6M$19.0M1.2%+675.7%
BCRX BIOCRYST PHARMACEUTICALS INCHealthcare2.0M$18.9M1.2%+46.5%
AVTX AVALO THERAPEUTICS INCHealthcare1.2M$18.4M1.2%Held
RMR RMR GROUP INC/THE - AServices media1.1M$17.8M1.1%Held
RYAM RAYONIER ADVANCED MATERIALSOther1.6M$17.7M1.1%-11.1%
GERN GERON CORPHealthcare11.2M$16.7M1.0%+24.4%
BNTC BENITEC BIOPHARMA INCHealthcare1.4M$15.3M1.0%+38.5%
ITGR INTEGER HOLDINGS CORPHealthcare172.0K$15.1M0.9%+68.6%
KROS KEROS THERAPEUTICS INCHealthcare1.4M$15.0M0.9%+277.5%
JACK JACK IN THE BOX INCConsumer discretionary1.5M$14.9M0.9%+78.1%
JCAP JEFFERSON CAPITAL INCFinancials750.0K$14.4M0.9%+25.0%
AURA AURA BIOSCIENCES INCHealthcare2.1M$14.2M0.9%Held
USNA USANA HEALTH SCIENCES INCMaterials810.1K$14.2M0.9%+38.5%
PCVX VAXCYTE INCHealthcare238.7K$13.9M0.9%New
MDXG MIMEDX GROUP INCHealthcare3.4M$13.4M0.8%+40.6%
AH30 ASSERTIO HOLDINGS INC692.3K$13.2M0.8%+17.9%
DSGR DISTRIBUTION SOLUTIONS GROUPConsumer discretionary494.6K$13.0M0.8%+49.9%
HLXC HELIX ACQUISITION CORP-CL AFinancials1.3M$12.7M0.8%New
APYX APYX MEDICAL CORPHealthcare3.4M$12.7M0.8%-13.4%
JANX JANUX THERAPEUTICS INCHealthcare809.9K$11.3M0.7%New
GLUE MONTE ROSA THERAPEUTICS INCHealthcare652.0K$10.7M0.7%+1024.3%
FLWS 1-800-FLOWERS.COM INC-CL AConsumer discretionary3.4M$10.3M0.6%Held
XFOR X4 PHARMACEUTICALS INCHealthcare2.4M$10.1M0.6%Held

13F filing history

PeriodFormFiledEntriesReported valueFlagsSource
Q1 202613F-HRMay 15, 2026152$2.72B canonicalSEC ↗
Q4 202513F-HRFeb 13, 2026153$3.02B canonicalSEC ↗
Q3 202513F-HRNov 14, 2025153$2.88B canonicalSEC ↗
Q2 202513F-HRAug 14, 2025158$2.55B canonicalSEC ↗
Q1 202513F-HRMay 15, 2025145$2.52B canonicalSEC ↗
Q4 202413F-HRFeb 14, 2025137$2.33B canonicalSEC ↗
Q3 202413F-HRNov 14, 2024140$1.98B canonicalSEC ↗
Q2 202413F-HR/ANEW HOLDINGSAug 20, 2024130$1.71B canonicalSEC ↗
Q2 202413F-HRAug 14, 2024128$1.70B canonicalSEC ↗
Q1 202413F-HRMay 15, 2024124$1.75B canonicalSEC ↗